The infectious respiratory disease COVID-19, caused by the novel Coronavirus SARS-CoV-2, is spreading all over the globe with an alarming speed, and has turned into a pandemic ever since its first appearance in December 2019.
The medical diagnosis of COVID-19 is challenging, since its symptoms are highly variable and can range from asymptomatic condition to flu-like or even life-threatening symptoms like respiratory distress.
Therefore, the WHO recommends screening for the COVID-19 virus via nucleic acid amplification tests, such as RT-PCR.
The Convergys®
POC RT-PCR COVID-19 Testing Platform
Intended use:
Our Testing Platform integrates WHO endorsed RT-PCR methodology into a convenient and easy-to-use format. The pre-filled, single-use cartridges take care of the complete patient sample processing, including RNA extraction, purification and RT-PCR amplification; all within 90 minutes.
The Convergys® POC RT-PCR COVID-19 Testing Platform directly detects SARS-CoV-2 genetic material.
Discover established Convergys® range of Hematology, Electrolyte Analysis, Blood Gases, Urinalysis and Biochemistry.
The élégance® Glucometer Range offers you and your healthcare providers a comfortable, precise and extremely reliable way to manage your diabetes.
With just 0.5 μl sample volume and a 5 second reading time our elegance series will make your blood glucose monitoring experience as comfortable and as painless as possible.
This rapid chromatographic immunoassay detects the Nucleocapsid protein of SARS-CoV-2, the pathogen causing the COVID-19 disease. The test kit works with nasopharyngeal patient swabs and
The Rinat Akhmetov Foundation supplied the Heart Institute of the Ministry of Health of Ukraine with a new Convergys® POC RT-PCR Nucleic Acid detection System
Convergent Technologies GmbH & Co. KG is pleased to announce the launch of Convergys® POC RT-PCR COVID-19 Detection Kit. The test kit is designed for
Convergent Technologies is an emerging leader in the field of Integrated Healthcare Solutions. We strive to provide innovative and cost-effective healthcare solutions enabling people live healthier lives.
Our state-of-the-art diagnostic systems concentrate on early detection, targeted screening, evaluation and monitoring of diseases.
Convergent Technologies GmbH & Co. KG
Ringstrasse 14
35091 Coelbe, Germany
Tel: +49 6421 88699-48
Fax: +49 6421 88699-58
© Convergent Technologies. All rights reserved.
